Evaluation of avocado and soybean unsaponifiable extracts for treatment of horses with experimentally induced osteoarthritis

American Journal of Veterinary Research

Volumn 68, Issue 6, 2007, Pages 598-604

  Kawcak, Christopher E ^a   Frisbie, David D ^a   McIlwraith, Wayne ^a   Werpy, Natasha M ^a   Park, Richard D ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLYCOSAMINOGLYCAN; MOLASSES; PIASCLEDINE; UNCLASSIFIED DRUG; VETOQUINOL;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE EROSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; GLYCOSAMINOGLYCAN METABOLISM; HEMARTHROSIS; JOINT EFFUSION; JOINT FUNCTION; NONHUMAN; OSTEOARTHRITIS; SYNOVIAL FLUID;

ANIMALS; HORSE DISEASES; HORSES; OSTEOARTHRITIS; PERSEA; PLANT EXTRACTS; SOYBEANS; TIME FACTORS;

ANIMALIA; EQUIDAE; GLYCINE MAX; PERSEA AMERICANA;

EID: 34447328060     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.6.598     Document Type: Article

References (24)

1. Caron JP, Genovese RL. Principles and practices of joint disease treatment. In: Ross RW, Dyson SJ, eds. Diagnosis and management of lameness in the horse. 2003;746-763.
2. Frisbie DD. Current and future treatments of equine joint disease, in Proceedings. 50th Annu Conv Am Assoc Equine Pract 2004;157-176.
3. Hauselmann HJ. Nutripharmaceuticals for osteoarthritis. Best Pract Res Clin Rheumatol 2001;15:595-607.
4. Appelboom T, Schuermans J, Verbruggen G, et al. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study Scand J Rheumatol 2001;30:242-247.
5. Arjmandi BH, Khalil DA, Lucas EA, et al. Soy protein may alleviate osteoarthritis symptoms. Phytomedicine 2004;11:567-575.
6. Blotman F, Maheu E, Wulwik A, et al. Efficacy and safety of avocado/ soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev Rhum Engl Ed 1997;64:825-834.
7. Boumediene K, Felisaz N, Bogdanowicz P, et al. Avocado/soya unsaponifiables enhance the expression of transforming growth factor beta1 and beta2 in cultured articular chondrocytes. Arthritis Rheum 1999;42:148-156.
8. Henrotin YE, Sanchez C, Deberg MA, et al. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J Rheumatol 2003;30:1825-1834.
9. 2 production by human articular chondrocytes. Clin Rheumatol 1998;17:31-39.
10. Maheu E, Mazieres B, Valat JP, et al. Symptomatic efficacy of avocado/ soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum 1998;41:81-91.
11. Lequesne M, Maheu E, Cadet C, et al. Structural effect of avocado/ soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum 2002;47:50-58.
12. Cake MA, Read RA, Guillou B, et al. Modification of articular cartilage and subchondral bone pathology in an ovine meniscectomy model of osteoarthritis by avocado and soya unsaponifiables (ASU). Osteoarthritis Cartilage 2000;8:404-411.
13. Ernst E. Avocado-soybean unsaponifiables (ASU) for osteoarthritis - a systematic review. Clin Rheumatol 2003;22:285-288.
14. Frisbie DD, Kawcak CE, Baxter GM, et al. Effects of 6α-methylprednisolone acetate on an equine osteochondral fragment exercise model. Am J Ver Res 1998;59:1619-1628.
15. Frisbie DD, Kawcak CE, Trotter GW, et al. Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model. Equine Vet J 1997;29:349-359.
16. Kawcak GE, Frisbie DD, Trotter GW, et al. Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation. Am J Ver Res 1997;58:1132-1140.
17. Kawcak CE, Norrdin RW, Frisbie DD, et al. Effects of osteochondral fragmentation and intra-articular triamcinolone acetonide treatment on subchondral bone in the equine carpus. Equine Vet J 1998;30:66-71.
18. Frisbie DD, Ghivizzani SC, Robbins PD, et al. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 2002;9:12-20.
19. Definition and classification of lameness. In: Guide for veterinary service and judging of equestrian events. Lexington, Ky: American Association of Equine Practitioners, 1991;19.
20. Alwan WH, Carter SD, Bennett D, et al. Glycosaminoglycans in horses with osteoarthritis. Equine Ver J 1991;23:44-47.
21. Ray CS, Poole AR, McIlwraith CW. Use of synovial fluid and serum markers in articular cartilage, In: McIlwraith CW, Trotter GW, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996;203-216.
22. Billinghurst RC, Buxton EM, Edwards MG, et al. Use of an antineoepitope antibody for identification of type-II collagen degradation in equine articular cartilage. Am J Ver Res 2001;62:1031-1039.
23. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982;9:247-248.
24. Frisbie DD, Kawcak CE, Trotter GW, et al. The assessment of chondrocyte proteoglycan metabolism using molecular sieve column chromatography as compared to three commonly utilized techniques. Osteoarthritis Cartilage 1998;6:137-145.